Inhibited apoptosis of synovial fluid lymphocytes in children with juvenile idiopathic arthritis is associated with increased expression of myeloid cell leukemia 1 and XIAP proteins

Journal of Rheumatology

Volumn 33, Issue 8, 2006, Pages 1684-1690

  Smolewska, Elzbieta ^a,b   Stanczyk, Jerzy ^a   Robak, Tadeusz ^b   Smolewski, Piotr ^b  

^a Department of Pediatric Cardiology and Rheumatological Clinic for Children ^*  (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Juvenile idiopathic arthritis; Lymphocyte; Proteins; Synovial fluid

Indexed keywords

FLICE INHIBITORY PROTEIN; PROTEIN BAK; PROTEIN BCL W; PROTEIN BID; PROTEIN MCL 1; PROTEIN P53; X LINKED INHIBITOR OF APOPTOSIS;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE; MALE; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SYNOVIAL FLUID; UPREGULATION;

ADOLESCENT; APOPTOSIS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SYNOVIAL FLUID; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33746667799     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K. Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:442-9.
2. Catrina AI, Ulfgren AK, Lindblad S, Grondal L, Klareskog L. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 2002;61:934-6.
3. Hilbers I, Hansen T, Petrow PK, et al. Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium. Rheumatol Int 2003;23:75-81.
4. Salmon M, Scheel-Toellner D, Huissoon AP, et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997;99:439-46.
5. Zhang J, Bardos T, Mikecz K, Finnegan A, Giant TT. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol 2001;166:4981-6.
6. Cantwell MJ, Hua T, Zvaifler NJ, Kipps TJ. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1997;40:1644-52.
7. Youn J, Kim HY, Park JH, et al. Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappa B in synoviocytes obtained from patients with rheumatoid arthritis. Immunol Lett 2002;83:85-93.
8. Sun Y, Cheung HS. p53, proto-oncogene and rheumatoid arthritis. Semin Arthritis Rheum 2002;31:287-8.
9. Chou CT, Yang JS, Lee MR. Apoptosis in rheumatoid arthritis-expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 2001;193:110-6.
10. Taubert H, Thamm B, Meye A, et al. The p53 status in juvenile chronic arthritis and rheumatoid arthritis. Clin Exp Immunol 2000;122:264-9.
11. Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K 3rd, Pope RM. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 2000;164:5227-35.
12. Schedel J, Gay RE, Kuenzler P, et al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 2002;46:1512-8.
13. Yamasaki S, Kawakami A, Nakashima T, et al. Importance of NF-kappa B in rheumatoid synovial tissues: in situ NF-kappa B expression and in vitro study using cultured synovial cells. Ann Rheum Dis 2001;60:678-84.
14. Zhang HG, Huang N, Liu D, et al. Gene therapy that inhibits nuclear translocation of nuclear factor kappa B results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum 2000;43:1094-105.
15. Hayashida K, Shimaoka Y, Ochi T, Lipsky PE. Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up-regulate Bcl-xL expression by B cells in a CD49/CD29-CD106-dependent mechanism. J Immunol 2000;164:1110-6.
16. Smolewska E, Brózik H, Smolewski P, Biernacka-Zielinska M, Darzynkiewicz Z, Stanczyk J. Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2003;62:761-3.
17. Smolewska E, Brózik H, Smolewski P, Darzynkiewicz Z, Stanczyk J. Regulation of peripheral blood and synovial fluid lymphocyte apoptosis in juvenile idiopathic arthritis. Scand J Rheumatol 2004;33:7-12.
18. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
19. Darzynkiewicz Z, Bedner E, Smolewski P. In situ detection of DNA strand breaks in analysis of apoptosis by flow- and laser-scanning cytometry. Meth Mol Biol 2002;203:69-77.
20. Kornblau SM, Womble M, Cade JS, Lemker E, Qiu YH. Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia. Leukemia 2005;19:1550-7.
21. Isomaki P, Soderstrom KO, Punnonen J, et al. Expression of bcl-2 in rheumatoid arthritis. Br J Rheumatol 1996;35:611-9.
22. Kurowska M, Rudnicka W, Kontny E, et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 2002;169:1760-7.
23. Yang L, Thornton S, Grom AA. Interleukin-15 inhibits sodium nitroprusside-induced apoptosis of synovial fibroblasts and vascular endothelial cells. Arthritis Rheum 2002;46:3010-4.
24. Pignatti P, Massa M, Travaglino P, Meazza C, Martini A, De Benedetti F. Activation-induced cell death and Fas-induced apoptosis in patients with systemic or pauciarticular juvenile idiopathic arthritis. Clin Exp Rheumatol 2001;19:339-44.
25. Knipp S, Feyen O, Ndagijimana J, Niehues T. Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis. Rheumatol Int 2003;23:112-5.
26. Perlman H, Liu H, Georganas C, et al. Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum 2001;44:2899-908.
27. Michels J, Johnson PW, Packham G. Mcl-1. Int J Biochem Cell Biol 2005;37:267-71.
28. Holcik M. Translational upregulation of the X-linked inhibitor of apoptosis. Ann NY Acad Sci 2003;1010:249-58.
29. Craig RW. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 2002;16:444-54.
30. Malinge S, Monni R, Bernard O, Penard-Lacronique V. Activation of the NF-kappa B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK alpha. Oncogene 2006 Jan 23; [Epub ahead of print].
31. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-kappa B: a key to survival. J Cell Sci 2004;117:5197-208.
32. Nakamura H, Kawakami A, Yamasaki S, et al. Expression and function of X chromosome-linked inhibitor of apoptosis protein in Sjogren's syndrome. Lab Invest 2000;80:1421-7.
33. Sharief MK, Semra YK. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2001;119:350-7.
34. Semra YK, Seidi OA, Sharief MK. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins. J Neuroimmunol 2002;122:159-66.